p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved

Noreen M. Walsh; Andrea Saggini; Sylvia Pasternak; Michael D. Carter; Kirsten Fleming; Thai Yen Ly; Steve Doucette

doi:10.1016/j.humpath.2020.01.001

p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved

Noreen M. Walsh, Andrea Saggini, Sylvia Pasternak, Michael D. Carter, Kirsten Fleming, Thai Yen Ly, Steve Doucette

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
页（从-至）	60-67
页数	8
期刊	Human Pathology
卷	97
DOI	https://doi.org/10.1016/j.humpath.2020.01.001
出版状态	已出版 - 3月 2020

!!!ASJC Scopus Subject Areas

病理学与法医学

访问文件

10.1016/j.humpath.2020.01.001

其它文件与链接

引用此

Walsh, N. M., Saggini, A., Pasternak, S., Carter, M. D., Fleming, K., Ly, T. Y., & Doucette, S. (2020). p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved. Human Pathology, 97, 60-67. https://doi.org/10.1016/j.humpath.2020.01.001

@article{e3a29d5473aa45fb841a52033e80fdc4,

title = "p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved",

author = "Walsh, {Noreen M.} and Andrea Saggini and Sylvia Pasternak and Carter, {Michael D.} and Kirsten Fleming and Ly, {Thai Yen} and Steve Doucette",

note = "Funding Information: Funding/Support: The study was supported by research grants from the Nova Scotia Health Authority Research Fund and the DPLM Fund for Molecular Pathology housed at the QEII Foundation., Halifax, Nova Scotia, Canada. Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = mar,

doi = "10.1016/j.humpath.2020.01.001",

language = "English",

volume = "97",

pages = "60--67",

journal = "Human Pathology",

issn = "0046-8177",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - p63 expression in Merkel cell carcinoma

T2 - comparative immunohistochemistry invokes TAp63 as the dominant isoform involved

AU - Walsh, Noreen M.

AU - Saggini, Andrea

AU - Pasternak, Sylvia

AU - Carter, Michael D.

AU - Fleming, Kirsten

AU - Ly, Thai Yen

AU - Doucette, Steve

N1 - Funding Information: Funding/Support: The study was supported by research grants from the Nova Scotia Health Authority Research Fund and the DPLM Fund for Molecular Pathology housed at the QEII Foundation., Halifax, Nova Scotia, Canada. Publisher Copyright: © 2020 Elsevier Inc.

PY - 2020/3

Y1 - 2020/3

UR - http://www.scopus.com/inward/record.url?scp=85079854649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079854649&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2020.01.001

DO - 10.1016/j.humpath.2020.01.001

M3 - Article

C2 - 31978504

AN - SCOPUS:85079854649

SN - 0046-8177

VL - 97

SP - 60

EP - 67

JO - Human Pathology

JF - Human Pathology

ER -

p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此